Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis (NCT06173882) | Clinical Trial Compass
UnknownNot Applicable
Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis
China90 participantsStarted 2022-08-01
Plain-language summary
The objective of this randomized controlled clinical trial is to compare the therapeutic effect of moxibustion on allergic rhinitis. The main questions it aims to answer are:
Based on randomized controlled trials, verify the effectiveness of moxibustion in treating allergic rhinitis Based on a real-time monitoring system for human surface temperature, discuss the differences in therapeutic effects of different moxibustion doses on allergic rhinitis
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
* Those who meet the diagnostic criteria of Chinese and Western medicine for AR;
* Age range from 18 to 75 years old, regardless of gender;
* Patients and their families are informed and agree to the study.
Exclusion criteria
* Those who are undergoing other traditional Chinese medicine external treatment methods;
* Those who have taken traditional Chinese medicine recently or during treatment;
* Individuals who are allergic to heavy moxibustion smoke and dust;
* Individuals with concomitant bronchial asthma or other respiratory system diseases;
* Patients with severe skin diseases or ulcers in the local area where moxibustion is applied;
* Pregnant and lactating patients;
* Patients with severe diseases of important organs such as the heart, liver, lungs, and kidneys;
* Those who are unable to receive treatment according to regulations due to inconvenience in work, study, transportation, or personal activities
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Rhinitis VAS Visual Analog Scale（AR-VAS）
Timeframe: Change from baseline VAS scores at week 0(before treatment)，4 and 12.
2
Total nasal symptom scores（TNSS）
Timeframe: Change from baseline TNSS scores at week 0(before treatment)，4 and 12.
Trial details
NCT IDNCT06173882
SponsorHenan University of Traditional Chinese Medicine